Contributions of A1c_Alder

Contributions by A1c_Alder, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 11,204 edits includes activity predating the current log.

1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 18,573 ±0 ce, tighten prose
2. 00:44, 28 May 2026 (diff | hist) Sharps disposal 8,240 +1,675 expand §Scope and definitions
3. 13:50, 10 May 2026 (diff | hist) Talk:Haemoglobin A1c 748 +102 /* Variant interference */ reply
4. 08:24, 12 Apr 2026 (diff | hist) Beyond-use date 23,171 ±0 the vial strength in the example was inconsistent between two paragraphs
5. 04:51, 30 Mar 2026 (diff | hist) Lixisenatide 4,195 ±0 m the storage condition applies to the unopened pen; say so
6. 09:45, 3 Feb 2026 (diff | hist) Talk:Haemoglobin A1c 400 +129 /* Weighting towards recent weeks */ new section
7. 12:55, 22 Dec 2025 (diff | hist) ChinaPeptides 14,979 +220 m rm the comparison with another supplier; there is no common basis for it
8. 02:14, 9 Nov 2025 (diff | hist) Mass spectrometry 5,612 ±0 add the system-suitability criteria the method actually specifies
9. 16:25, 11 Oct 2025 (diff | hist) Sangon Biotech 13,424 +1,024 state the city and province of the registered address
10. 19:43, 14 Aug 2025 (diff | hist) Multi-dose vial 18,736 +539 de-orphan
11. 23:08, 6 Aug 2025 (diff | hist) Sterility testing 4,438 ±0 m add the cross-link to the compendial chapter
12. 16:52, 28 Jul 2025 (diff | hist) Semaglutide 9,799 ±0 clarify that the peptide backbone is acylated rather than PEGylated
13. 06:15, 3 Jul 2025 (diff | hist) Beyond-use date 15,368 ±0 expand §Sterile preparations under USP <797>
14. 12:18, 19 Jun 2025 (diff | hist) Purity claim inflation 5,156 +561 convert the service comparison to a table
15. 21:59, 30 Apr 2025 (diff | hist) Liraglutide 5,268 +18 clarify that the peptide backbone is acylated rather than PEGylated
16. 04:02, 29 Apr 2025 (diff | hist) Body composition assessment 4,384 ±0 add the seasonal variation point, sourced
17. 22:40, 13 Apr 2025 (diff | hist) Sarcopenia 3,440 ±0 m expand §Relevance to weight reduction
18. 00:31, 21 Feb 2025 (diff | hist) Body composition assessment 4,060 +707 m rm the extrapolation from a research assay to a clinical one
19. 10:42, 3 Feb 2025 (diff | hist) International nonproprietary name 2,789 +34 state plainly that the research-use-only form is not approved for human use
20. 14:52, 21 Jan 2025 (diff | hist) Deamidation 3,497 ±0 correct the resolution formula — the denominator is the sum of the widths
21. 15:28, 17 Dec 2024 (diff | hist) Sarcopenia 1,830 +233 convert a hard-coded date to the house format
22. 11:31, 5 Nov 2024 (diff | hist) Baseline laboratory panel 1,947 ±0 add category for laboratory medicine
23. 01:49, 4 Nov 2024 (diff | hist) HOMA-IR 2,285 +458 m add category for laboratory medicine
24. 11:48, 22 Oct 2024 (diff | hist) Baseline laboratory panel 1,276 +1,276 N create article — laboratory stub
25. 09:24, 14 Oct 2024 (diff | hist) Dose escalation schedule 1,918 ±0 rm the individualised advice — the article describes, it does not instruct
26. 22:46, 21 Sep 2024 (diff | hist) Fasting insulin 1,061 ±0 m give the coefficient of variation with the level it was measured at
27. 22:35, 30 Aug 2024 (diff | hist) Lyophilisation 1,963 +38 fix a broken wikilink